During the past decade, Shuguang Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shuguang Hospital" #1 sponsor was "ShuGuang Hospital" with 6 trials, followed by "Shanghai University of Traditional Chinese Medicine" with 2 trials sponsored, "Huashan Hospital" with 1 trials sponsored, "Jidong Jia" with 1 trials sponsored and "Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shuguang Hospital" #1 collaborator was "Hubei Hospital of Traditional Chinese Medicine" with 4 trials as a collaborator, "Jingmen No.1 People's Hospital" with 4 trials as a collaborator, "Beijing Ditan Hospital" with 3 trials as a collaborator, "Ruijin Hospital" with 3 trials as a collaborator and "Shanghai Zhongshan Hospital" with 3 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Shuguang Hospital" are "COVID-19" (2 trials), "Asthma" (1 trials), "Chronic Heart Failure" (1 trials), "Chronic Hepatitis B" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Shuguang Hospital" in a lesser frequency.

Most popular intervention types in "Shuguang Hospital" are "Drug" (12 trials), "Device" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baduanjin exercise" (1 trials), "Carboplatin" (1 trials), "Entecavir + Fuzheng Huayu Tablet" (1 trials) and "Entecavir + Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shuguang Hospital" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Shuguang Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Shuguang Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shuguang Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".